Fresenius SE Return on Investment 2016-2024 | FSNUY

Current and historical return on investment (ROI) values for Fresenius SE (FSNUY) over the last 10 years.
Fresenius SE ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-09-30 $0.86B $33.39B 2.56%
2024-06-30 $0.69B $32.92B 1.91%
2024-03-31 $1.00B $33.71B 2.41%
2023-12-31 $1.24B $33.67B 2.64%
2023-09-30 $2.51B $44.82B 4.82%
2023-06-30 $3.02B $53.46B 5.58%
2023-03-31 $3.33B $55.79B 6.13%
2022-12-31 $3.50B $53.95B 6.49%
2022-09-30 $4.09B $53.65B 7.58%
2022-06-30 $4.39B $53.95B 8.09%
2022-03-31 $4.72B $54.01B 8.68%
2021-12-31 $4.92B $54.32B 9.17%
2021-09-30 $4.86B $54.60B 9.30%
2021-06-30 $4.97B $54.62B 9.66%
2021-03-31 $4.98B $51.03B 10.00%
2020-12-31 $5.01B $48.94B 10.27%
2020-09-30 $5.19B $51.46B 10.70%
2020-06-30 $5.14B $47.84B 10.82%
2020-03-31 $5.16B $46.76B 10.95%
2019-12-31 $5.19B $47.81B 10.99%
2019-09-30 $5.18B $47.67B 11.79%
2019-06-30 $5.13B $46.30B 12.71%
2019-03-31 $6.19B $46.93B 16.49%
2018-12-31 $6.20B $34.78B 17.74%
2018-09-30 $6.10B $33.51B 16.50%
2018-06-30 $6.20B $35.04B 15.64%
2018-03-31 $5.16B $36.45B 12.48%
2017-12-31 $5.19B $42.80B 12.11%
2017-09-30 $5.24B $44.26B 12.67%
2017-06-30 $5.12B $41.95B 13.14%
2017-03-31 $5.03B $42.30B 13.44%
2016-12-31 $4.79B $36.81B 13.52%
2016-09-30 $11.39B $34.85B 32.57%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $23.628B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.868B 19.58
Encompass Health (EHC) United States $12.183B 25.83
DaVita (DVA) United States $10.978B 15.44
Chemed (CHE) United States $8.483B 26.66
Elanco Animal Health (ELAN) United States $6.417B 13.74
Option Care Health (OPCH) United States $5.441B 24.25
RadNet (RDNT) United States $4.587B 291.14
Amedisys (AMED) United States $3.105B 20.89
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.054B 22.55
Astrana Health (ASTH) United States $1.524B 37.75
U.S Physical Therapy (USPH) United States $1.213B 31.31
Aveanna Healthcare Holdings (AVAH) United States $1.169B 66.56
Pennant (PNTG) United States $1.042B 38.25
Atai Life Sciences (ATAI) Germany $0.331B 0.00
Daxor (DXR) United States $0.037B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00